Clinical Trial: Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above

U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285265) titled 'Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above' on Dec. 03.

Brief Summary: The primary objective of this study is to evaluate the tolerability, reactogenicity and safety of 2 injections (approximately 2 months apart) of three different dose levels of ABO1108 in adults aged 40 years or above.

Study Start Date: May 27

Study Type: INTERVENTIONAL

Condition: Varicella-zoster Virus

Intervention: BIOLOGICAL: ABO1108

Formulation for injection

DRUG: Placebo

0.9% sodium chloride (normal saline) injection

BIOLOGICAL: SHINGRIX

* Formulation for injection

Recruitment Status: ACTIVE_N...